Syneos Health Appoints Greg Licholai as Chief Medical Officer to Advance Next-Generation Drug Development
Summary
Syneos Health appointed Greg Licholai as Chief Medical Officer, effective June 1. The company said the hire will strengthen its medical depth and therapeutic expertise as it supports biopharmaceutical customers through complex drug development work. Licholai will help define and execute medical and scientific strategy across clinical and commercial teams. The move reinforces Syneos Health’s push to deliver more connected, insight-driven services that speed therapies to market.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected